Markus Warmuth

GLUE

Markus Warmuth serves as director, officer: President & CEO at Monte Rosa Therapeutics, Inc. (GLUE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$423.2K

Net Position

Net Seller

$423.2K

Companies Traded

GLUE

Active Period

Jan 2026 – Apr 2026

3 total trades

Most Recent

Sell GLUE

Apr 15, 2026 · $141.1K

Markus Warmuth's Insider Trading at Monte Rosa Therapeutics, Inc. (GLUE)

Buys

0 · $0.00

Sells

3 · $423.2K

Total Shares Bought

Total Shares Sold

23,601

GLUE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 15, 2026	Sell	8,000	$17.64	$141.1K	605,471
Jan 9, 2026	Sell	5,466	$23.49	$128.4K	620,696
Jan 5, 2026	Sell	10,135	$15.17	$153.7K	624,403

Related Insiders

Philip Nickson

officer: Chief Business & Legal Officer

GLUESell · Apr 10, 2026

Edmund Dunn

Principal Accounting Officer

GLUESell · Mar 5, 2026

Filip Janku

officer: Chief Medical Officer

GLUESell · Feb 24, 2026

Jennifer Champoux

officer: Chief Operating Officer

GLUESell · Jan 5, 2026

Sharon Townson

officer: Chief Scientific Officer

GLUESell · Jan 5, 2026

Explore More Insider Trading Data

GLUE Insider Trading Activity

View all insider trades at Monte Rosa Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity